Statistics from Altmetric.com
Kuwana M, Blair C, Takahashi T, et al. Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis. Ann of Rheum Dis 2020;79:626-34.
In table 1 the pvr unit should be dyne·s/cm5 and the number of FC III in SSc/Mono should be 39(70) not 36(77)
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.